Trial
NCT02142725
Phosphatidylcholine (LT-02) for Induction of Remission in Ulcerative Colitis
Phase IIITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
Dr. Falk Pharma GmbH
Collaborators
—
Condition
Ulcerative Colitis
Intervention
LT-02
Why stopped
IDMC recommendation
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-02-09